ArticleAging2024

HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma.

Liang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.